China · Delayed Price · Currency is CNY Xiangxue Pharmaceutical Statistics
Total Valuation
SHE:300147 has a market cap or net worth of CNY 4.13 billion. The enterprise value is 5.78 billion.
| Market Cap | 4.13B |
| Enterprise Value | 5.78B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300147 has 661.28 million shares outstanding. The number of shares has decreased by -0.45% in one year.
| Current Share Class | 661.28M |
| Shares Outstanding | 661.28M |
| Shares Change (YoY) | -0.45% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 1.59% |
| Float | 483.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.79 |
| PB Ratio | -17.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 58.66 |
| P/OCF Ratio | 42.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.60, with an EV/FCF ratio of 82.09.
| EV / Earnings | n/a |
| EV / Sales | 3.91 |
| EV / EBITDA | 40.60 |
| EV / EBIT | n/a |
| EV / FCF | 82.09 |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | 10.02 |
| Debt / FCF | 20.40 |
| Interest Coverage | -0.18 |
Financial Efficiency
Return on equity (ROE) is -285.54% and return on invested capital (ROIC) is -4.26%.
| Return on Equity (ROE) | -285.54% |
| Return on Assets (ROA) | -0.46% |
| Return on Invested Capital (ROIC) | -4.26% |
| Return on Capital Employed (ROCE) | 36.63% |
| Weighted Average Cost of Capital (WACC) | 9.39% |
| Revenue Per Employee | 556,044 |
| Profits Per Employee | -536,108 |
| Employee Count | 2,662 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 3.72 |
Taxes
In the past 12 months, SHE:300147 has paid 47.83 million in taxes.
| Income Tax | 47.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.65% in the last 52 weeks. The beta is 0.54, so SHE:300147's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -45.65% |
| 50-Day Moving Average | 7.57 |
| 200-Day Moving Average | 9.14 |
| Relative Strength Index (RSI) | 31.05 |
| Average Volume (20 Days) | 9,677,687 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300147 had revenue of CNY 1.48 billion and -1.43 billion in losses. Loss per share was -2.18.
| Revenue | 1.48B |
| Gross Profit | 417.11M |
| Operating Income | -51.35M |
| Pretax Income | -1.36B |
| Net Income | -1.43B |
| EBITDA | 126.72M |
| EBIT | -51.35M |
| Loss Per Share | -2.18 |
Balance Sheet
The company has 177.41 million in cash and 1.44 billion in debt, with a net cash position of -1.26 billion or -1.91 per share.
| Cash & Cash Equivalents | 177.41M |
| Total Debt | 1.44B |
| Net Cash | -1.26B |
| Net Cash Per Share | -1.91 |
| Equity (Book Value) | -237.24M |
| Book Value Per Share | -0.96 |
| Working Capital | -5.19B |
Cash Flow
In the last 12 months, operating cash flow was 98.15 million and capital expenditures -27.68 million, giving a free cash flow of 70.46 million.
| Operating Cash Flow | 98.15M |
| Capital Expenditures | -27.68M |
| Depreciation & Amortization | 178.07M |
| Net Borrowing | 33.97M |
| Free Cash Flow | 70.46M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 28.18%, with operating and profit margins of -3.47% and -96.41%.
| Gross Margin | 28.18% |
| Operating Margin | -3.47% |
| Pretax Margin | -91.68% |
| Profit Margin | -96.41% |
| EBITDA Margin | 8.56% |
| EBIT Margin | -3.47% |
| FCF Margin | 4.76% |
Dividends & Yields
SHE:300147 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.45% |
| Shareholder Yield | 0.45% |
| Earnings Yield | -34.53% |
| FCF Yield | 1.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 14, 2014. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 14, 2014 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |